And as the world of medicine moves towards the dendritic cell approach of therapy this device and it’s future enhancements will rule the manufacturing space. Maybe NWBO will look at a royalty type deal when and if the device becomes available globally as it will be needed by hundreds of emerging biotechs eager to get into the DC approach. IMO